Table 4 Adverse events = classified as related to the drug, for all patients during the study period
ASAQ (n = 144) | AL (n = 144) | Total | p value | |
|---|---|---|---|---|
Asthenia | 61 (42.4 %) | 13 (9.0 %) | 74 (25.7 %) | <0.001 |
Anorexia | 27 (18.8 %) | 12 (8.3 %) | 39 (13.5 %) | 0.010 |
Vomiting | 11 (7.6 %) | 10 (6.9 %) | 21 (7.3 %) | 0.821 |
Cough | 5 (3.5 %) | 7 (4.9 %) | 12 (4.2 %) | 0.555 |
Abdominal Pain | 6 (4.2 %) | 2 (1.4 %) | 8 (2.8 %) | 0.151 |
Diarrhoea | 4 (2.8 %) | 2 (1.4 %) | 6 (2.1 %) | 0.409 |
Itching | 3 (2.1 %) | 1 (0.7 %) | 4 (1.4 %) | 0.314 |
Nausea | 1 (0.7 %) | 1 (0.7 %) | 2 (0.7 %) | 1.000 |